GO:0008448 N-acetylglucosamine-6-phosphate deacetylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008448 describes the enzymatic activity that removes an acetyl group from N-acetyl-D-glucosamine 6-phosphate (GlcNAc-6-P) to produce D-glucosamine 6-phosphate and acetate.
• The enzyme is a metal-dependent amidohydrolase that functions in the amino sugar catabolic pathway, allowing cells to utilize GlcNAc as a carbon and nitrogen source.
• N-acetylglucosamine-6-phosphate deacetylase (NagA) is conserved from bacteria to humans and is essential for chitin degradation in chitinolytic bacteria such as Chitiniphilus shinanonensis.
• Structural studies reveal that the enzyme forms tetramers or other quaternary assemblies, and oligomerization is important for catalytic efficiency and stability.
• In humans, the enzyme is present in erythrocytes and liver cells, and its activity is implicated in aminosugar metabolism and host-pathogen interactions.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of NagA function in health and disease.
Description
N-acetylglucosamine-6-phosphate deacetylase (EC 3.5.1.25) catalyzes the hydrolysis of N-acetyl-D-glucosamine 6-phosphate to D-glucosamine 6-phosphate and acetate, a key step in the amino sugar catabolic pathway. This enzymatic activity, annotated as GO:0008448, is essential for the utilization of N-acetylglucosamine (GlcNAc) as a carbon and nitrogen source in bacteria and for the recycling of amino sugars in higher organisms. The enzyme belongs to the amidohydrolase superfamily and requires a divalent metal ion for catalysis. In chitinolytic bacteria such as Chitiniphilus shinanonensis, NagA is indispensable for chitin degradation, a process important for nutrient cycling and microbial pathogenesis. In humans, the enzyme is expressed in erythrocytes and liver cells, where it contributes to aminosugar metabolism and may influence host-pathogen interactions. Understanding GO:0008448 is therefore relevant to microbiology, metabolic engineering, and human disease research.
N-acetylglucosamine-6-phosphate deacetylase activity At A Glance
| GO ID | GO:0008448 |
|---|---|
| GO term | N-acetylglucosamine-6-phosphate deacetylase activity |
| Ontology | molecular_function |
| Synonym | 2-acetamido-2-deoxy-D-glucose-6-phosphate amidohydrolase activity; acetylaminodeoxyglucosephosphate acetylhydrolase activity; acetylglucosamine phosphate deacetylase activity; N-acetyl-D-glucosamine-6-phosphate amidohydrolase activity |
| Major function | Catalyzes the deacetylation of N-acetyl-D-glucosamine 6-phosphate to D-glucosamine 6-phosphate and acetate |
| Reaction | H2O + N-acetyl-D-glucosamine 6-phosphate = acetate + D-glucosamine 6-phosphate |
| Enzyme class | Hydrolase (amidohydrolase) |
| Cofactor | Divalent metal ion (e.g., Zn2+ or Fe2+) |
| Pathway | Amino sugar and nucleotide sugar metabolism |
What Is GO:0008448?
GO:0008448 is defined as the catalysis of the reaction: H2O + N-acetyl-D-glucosamine 6-phosphate = acetate + D-glucosamine 6-phosphate. In other words, it is the enzymatic removal of an acetyl group from N-acetyl-D-glucosamine 6-phosphate, yielding D-glucosamine 6-phosphate and acetate. This activity is also known as N-acetyl-D-glucosamine-6-phosphate amidohydrolase, acetylaminodeoxyglucosephosphate acetylhydrolase, acetylglucosamine phosphate deacetylase, and 2-acetamido-2-deoxy-D-glucose-6-phosphate amidohydrolase.
Why Is N-acetylglucosamine-6-phosphate deacetylase activity Important in Cell Biology?
GO:0008448 is important because it represents a critical step in the catabolism of N-acetylglucosamine, a major component of chitin, peptidoglycan, and glycoproteins. In bacteria, this activity enables the utilization of chitin as a carbon and nitrogen source, which is essential for environmental nutrient cycling and for the virulence of certain pathogens. In humans, the enzyme participates in the salvage and degradation of amino sugars, and its dysfunction may contribute to metabolic disorders. Moreover, the enzyme is a potential target for antimicrobial and anticancer therapies, as its inhibition could disrupt cell wall or glycoprotein biosynthesis.
• Enables bacterial chitin utilization, a key process in marine carbon cycling and microbial ecology.
• Provides a route for GlcNAc catabolism in human cells, linking amino sugar metabolism to energy production.
• Is conserved across species, making it a model for studying amidohydrolase mechanism and evolution.
• Its structural plasticity and oligomerization states influence catalytic efficiency and allosteric regulation.
• Plays a role in host-pathogen interactions, as some pathogens rely on GlcNAc catabolism for survival.
• Represents a potential drug target for infections and metabolic diseases.
• Its activity can be measured in clinical samples, offering diagnostic potential.
• CRISPR-based editing of NagA orthologs can reveal its contribution to biofilm formation and virulence.
What Happens During N-acetylglucosamine-6-phosphate deacetylase activity?
Substrate Binding and Metal Coordination
In simple terms: The enzyme grabs the sugar molecule and uses a metal ion to help break a bond.
The enzyme binds N-acetyl-D-glucosamine 6-phosphate (GlcNAc-6-P) in its active site, where a divalent metal ion, typically Zn2+ or Fe2+, is coordinated by conserved histidine and aspartate residues. This metal ion polarizes the substrate's amide carbonyl, facilitating nucleophilic attack by a water molecule. Structural studies of Klebsiella pneumoniae NagA reveal that the metal is essential for catalysis and that mutations in metal-coordinating residues abolish activity.
Catalytic Hydrolysis
In simple terms: A water molecule splits the acetyl group off the sugar, releasing acetate.
Upon substrate binding, a water molecule is activated by a general base (likely Asp or Glu) to attack the amide carbon, forming a tetrahedral intermediate. The intermediate collapses, releasing acetate and yielding D-glucosamine 6-phosphate. This mechanism is characteristic of amidohydrolases and is supported by mutagenesis and kinetic studies.
Product Release and Enzyme Turnover
In simple terms: The products leave, and the enzyme is ready to work again.
After catalysis, D-glucosamine 6-phosphate and acetate are released from the active site, allowing the enzyme to undergo multiple turnovers. The enzyme's quaternary structure, often a tetramer, may influence product release and overall catalytic efficiency. In Pasteurella multocida, quaternary variations affect substrate affinity and turnover number.
Physiological Context and Pathway Integration
In simple terms: This reaction is part of a larger pathway that lets cells use amino sugars for energy.
The product D-glucosamine 6-phosphate is further metabolized to fructose-6-phosphate, entering glycolysis. In bacteria, this pathway is essential for chitin utilization, as shown in Chitiniphilus shinanonensis where NagA is required for growth on chitin. In humans, the enzyme operates in erythrocytes and liver cells, contributing to amino sugar recycling.
Key Genes Involved in GO:0008448 N-acetylglucosamine-6-phosphate deacetylase activity
The following genes and proteins are directly associated with N-acetylglucosamine-6-phosphate deacetylase activity (GO:0008448) or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| nagA (E. coli) | Encodes N-acetylglucosamine-6-phosphate deacetylase | Model for enzyme structure and function |
| nagA (Chitiniphilus shinanonensis) | Essential for chitin utilization | Chitin degradation and microbial ecology |
| nagA (Klebsiella pneumoniae) | Tetrameric deacetylase | Structural basis for oligomerization |
| nagA (Pasteurella multocida) | Quaternary variations | Allosteric regulation and stability |
| nagA (Thermus caldophilus) | Thermostable deacetylase | Biotechnological applications |
| nagA (Vibrio cholerae non-O1) | Activity against GlcNAc | Pathogen metabolism |
| nagB | Glucosamine-6-phosphate deaminase | Downstream enzyme in the pathway |
| nagK | N-acetylglucosamine kinase | Phosphorylates GlcNAc to GlcNAc-6-P |
| GFAT1 | Glutamine:fructose-6-phosphate amidotransferase | Hexosamine biosynthesis |
| O-GlcNAc transferase (OGT) | Adds O-GlcNAc to proteins | Cross-talk with amino sugar metabolism |
| O-GlcNAcase (OGA) | Removes O-GlcNAc | Regulation of O-GlcNAc cycling |
| Human NagA (AMDHD2) | N-acetylglucosamine-6-phosphate deacetylase | Human enzyme in erythrocytes |
| Rat NagA | Liver enzyme | Hepatocyte and Kupffer cell studies |
| Plasmodium falciparum NagA | Parasite enzyme | Malaria metabolism |
| Bacterial NagA homologs | Various | Antibiotic targets |
| Fungal NagA | Chitin catabolism | Fungal pathogenesis |
| Plant NagA | Amino sugar recycling | Plant development |
How Is N-acetylglucosamine-6-phosphate deacetylase activity Regulated?
The activity of N-acetylglucosamine-6-phosphate deacetylase is regulated at multiple levels. In bacteria, nagA is often part of the nag operon, which is induced by GlcNAc and repressed by glucose via carbon catabolite repression. In Pasteurella multocida, quaternary structural changes modulate enzyme activity, suggesting allosteric regulation. In humans, the enzyme may be regulated by substrate availability and post-translational modifications, though specific mechanisms remain to be fully elucidated.
N-acetylglucosamine-6-phosphate deacetylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| nagA (Chitiniphilus shinanonensis) | Chitin utilization and microbial ecology | Knockout in Chitiniphilus shinanonensis |
| nagA (Klebsiella pneumoniae) | Bacterial metabolism and virulence | Structural and knockout studies |
| Human AMDHD2 | Metabolic disorders and erythrocyte function | CRISPR knockout in human cell lines |
| Plasmodium falciparum NagA | Malaria | Parasite knockout and inhibitor testing |
| Rat NagA | Liver metabolism | Hepatocyte-specific knockout |
Bacterial Infections and Virulence
N-acetylglucosamine-6-phosphate deacetylase is essential for chitin utilization in Chitiniphilus shinanonensis and likely contributes to the virulence of pathogens that catabolize host-derived amino sugars. Inhibiting this enzyme could attenuate bacterial growth and biofilm formation, making it a potential antimicrobial target.
Metabolic Disorders
In humans, the enzyme participates in amino sugar metabolism, and its activity in erythrocytes and liver cells suggests a role in glucose homeostasis and metabolic disorders. Altered NagA activity may affect hexosamine flux and O-GlcNAc signaling, which are implicated in diabetes and cancer.
Malaria
Plasmodium falciparum possesses N-acetylglucosamine kinase and N-acetylglucosamine 6-phosphate deacetylase, indicating that the parasite relies on amino sugar metabolism for survival. Targeting these enzymes could provide new antimalarial strategies.
From N-acetylglucosamine-6-phosphate deacetylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NagA loss affect chitin utilization? | Knockout in Chitiniphilus shinanonensis |
| How does tetramerization affect catalysis? | Point mutations in Klebsiella pneumoniae NagA |
| Can human NagA be tagged for localization? | Knock-in of fluorescent tag in human cells |
| Does NagA overexpression alter amino sugar flux? | Overexpression in mammalian cells |
| Is NagA essential for Plasmodium survival? | Conditional knockout in P. falciparum |
| What is the role of NagA in liver metabolism? | Liver-specific knockout in rats |
How to Study the N-acetylglucosamine-6-phosphate deacetylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | Deacetylase activity | Kinetic studies and inhibitor screening |
| X-ray crystallography | Three-dimensional structure | Active site and oligomerization analysis |
| CRISPR knockout | Gene function | Loss-of-function studies |
| RNA-seq | Gene expression | Regulation and pathway analysis |
| Western blot | Protein levels | Expression validation |
| Site-directed mutagenesis | Residue function | Catalytic mechanism |
| Isothermal titration calorimetry | Binding affinity | Substrate and metal binding |
| Analytical ultracentrifugation | Oligomeric state | Quaternary structure |
Enzymatic Activity Assays
The deacetylase activity can be measured spectrophotometrically by coupling the release of acetate or D-glucosamine 6-phosphate to downstream reactions. Campbell et al. described an assay for rat liver NagA using GlcNAc-6-P as substrate. Such assays are essential for kinetic characterization and inhibitor screening.
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the structures of NagA from Klebsiella pneumoniae and Pasteurella multocida, revealing tetrameric assembly and metal coordination. These methods guide mutagenesis and drug design.
CRISPR-Cas9 Genome Editing
Knockout, point mutation, and knock-in models can be generated using CRISPR-Cas9 to study NagA function in various organisms. For example, knockout of nagA in Chitiniphilus shinanonensis confirmed its essential role in chitin utilization.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry can quantify nagA expression and protein levels under different conditions, providing insights into regulation and pathway integration.
How CRISPR Can Be Used to Study GO:0008448 N-acetylglucosamine-6-phosphate deacetylase activity
Knockout
CRISPR-Cas9 knockout of nagA or its human ortholog AMDHD2 can abolish enzyme activity, enabling studies of its role in chitin utilization, amino sugar metabolism, and host-pathogen interactions. Knockout models are valuable for validating drug targets.
Point Mutation
Introducing point mutations in catalytic residues (e.g., metal-coordinating histidines) can dissect the mechanism of GO:0008448. Such mutations in Klebsiella pneumoniae NagA have revealed essential residues for catalysis and tetramerization.
Knock-in
Knock-in of epitope tags or fluorescent proteins allows real-time tracking of NagA localization and interaction partners in live cells. This approach can be applied to human AMDHD2 to study its subcellular distribution.
Overexpression
Overexpression of NagA in bacterial or mammalian cells can increase flux through the amino sugar pathway, providing a tool to study metabolic effects and O-GlcNAc signaling.
How EDITGENE Supports N-acetylglucosamine-6-phosphate deacetylase activity Research
Researchers studying N-acetylglucosamine-6-phosphate deacetylase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for N-acetylglucosamine-6-phosphate deacetylase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AMDHD2 Knockout HEK293 Cell Line | EDJ-KQ51268 | Human | 51005 | Details Get a Quote |
| AMDHD2 Knockout HeLa Cell Line | EDJ-KQ56209 | Human | 51005 | Details Get a Quote |
| AMDHD2 Knockout A-549 Cell Line | EDJ-KQ64700 | Human | 51005 | Details Get a Quote |
| AMDHD2 Knockout HCT 116 Cell Line | EDJ-KQ73146 | Human | 51005 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About N-acetylglucosamine-6-phosphate deacetylase activity
What is N-acetylglucosamine-6-phosphate deacetylase activity?
It is the enzymatic activity (GO:0008448) that removes an acetyl group from N-acetyl-D-glucosamine 6-phosphate to produce D-glucosamine 6-phosphate and acetate.
What genes are involved in N-acetylglucosamine-6-phosphate deacetylase activity?
The primary gene is nagA in bacteria and AMDHD2 in humans, encoding the enzyme that catalyzes this reaction.
What is the function of NagA?
NagA catalyzes the deacetylation of GlcNAc-6-P, a key step in amino sugar catabolism, enabling cells to use GlcNAc as a carbon and nitrogen source.
Which diseases are associated with N-acetylglucosamine-6-phosphate deacetylase?
It is linked to bacterial infections, metabolic disorders, and malaria, as the enzyme is important for pathogen survival and human amino sugar metabolism.
How is N-acetylglucosamine-6-phosphate deacetylase regulated?
In bacteria, it is regulated by carbon catabolite repression and substrate induction; in humans, regulation may involve substrate availability and post-translational modifications.
What is the structure of N-acetylglucosamine-6-phosphate deacetylase?
It is a metal-dependent amidohydrolase that typically forms tetramers, with a conserved active site containing a divalent metal ion.
Can CRISPR be used to study N-acetylglucosamine-6-phosphate deacetylase?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect its function in various organisms.
What methods measure N-acetylglucosamine-6-phosphate deacetylase activity?
Enzymatic assays, mass spectrometry, and coupled spectrophotometric methods are commonly used to measure its activity.
Is N-acetylglucosamine-6-phosphate deacetylase a drug target?
Yes, it is considered a potential target for antimicrobial and anticancer therapies due to its role in pathogen metabolism and human amino sugar pathways.
Where is N-acetylglucosamine-6-phosphate deacetylase expressed in humans?
It is expressed in erythrocytes and liver cells, including hepatocytes, Kupffer cells, and sinusoidal endothelial cells.
Conclusion
N-acetylglucosamine-6-phosphate deacetylase activity (GO:0008448) is a fundamental enzymatic step in amino sugar metabolism, with critical roles in bacterial chitin utilization, human metabolic pathways, and host-pathogen interactions. Its conservation and structural features make it an attractive target for both basic research and therapeutic development. By leveraging CRISPR-based models and advanced analytical methods, researchers can uncover new insights into its regulation and disease relevance.
References
- 1. Ichioka R et al.. 2024. A novel N-acetylglucosamine-6-phosphate deacetylase that is essential for chitin utilization in the chitinolytic bacterium, Chitiniphilus shinanonensis.. J Appl Microbiol 135(5) PMID: 38724455
- 2. Manjunath L et al.. 2020. Quaternary variations in the structural assembly of N-acetylglucosamine-6-phosphate deacetylase from Pasteurella multocida.. Proteins PMID: 32865821
- 3. Campbell P et al.. 1990. N-acetylglucosamine-6-phosphate deacetylase in hepatocytes, Kupffer cells and sinusoidal endothelial cells from rat liver.. Hepatology 11(2):199-204 PMID: 2307398
- 4. Lee SY et al.. 2025. Structural Basis for Tetramerization of Klebsiella pneumoniae N-Acetylglucosamine-6-Phosphate Deacetylase.. J Microbiol Biotechnol 35:e2505019 PMID: 40877019
- 5. Weidanz JA et al.. 1996. N-acetylglucosamine kinase and N-acetylglucosamine 6-phosphate deacetylase in normal human erythrocytes and Plasmodium falciparum.. Br J Haematol 95(4):645-53 PMID: 8982040
- 6. Shin HJ et al.. 1999. Purification and characterization of N-Acetylglucosamine 6-phosphate deacetylase from Thermus caldophilus.. J Biosci Bioeng 88(3):319-22 PMID: 16232619
- 7. Campbell P et al.. 1987. Assay and properties of N-acetylglucosamine-6-phosphate deacetylase from rat liver.. Anal Biochem 166(1):134-41 PMID: 3674404
- 8. Yamano N et al.. 1996. Purification and characterization of N-acetylglucosamine 6-phosphate deacetylase with activity against N-acetylglucosamine from Vibrio cholerae non-O1.. Biosci Biotechnol Biochem 60(8):1320-3 PMID: 8987551
